⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

Official Title: A Multicenter Phase 3, Double-Blind, Placebo-Controlled Study Comparing Chemo-Immunotherapy (Paclitaxel-Carboplatin- Oregovomab) vs Chemotherapy (Paclitaxel-Carboplatin- Placebo) in Patients With Advanced Epithelial Ovarian, Fallopian Tube or Peritoneal Carcinoma

Study ID: NCT04498117

Study Description

Brief Summary: Study to compare the safety and efficacy of oregovomab versus placebo, administered in combination with specific cycles of a standard six-cycle chemotherapy regimen (paclitaxel and carboplatin), for the treatment of subjects with newly diagnosed advanced ovarian cancer who have undergone optimal debulking.

Detailed Description: Phase 3 double-blind, placebo-controlled, multi-center study to compare the safety and efficacy of four administrations of oregovomab 2 mg IV versus placebo, administered in combination with specific cycles of a standard six-cycle chemotherapy regimen (paclitaxel and carboplatin), for the treatment of subjects with newly diagnosed ovarian cancer who have undergone optimal debulking surgery and are either pending initiation of chemotherapy (Cohort 1 - Primary Surgery) or resumption of another three cycles of chemotherapy, having already completed three cycles of neoadjuvant chemotherapy (Cohort 2 - NACT + Interval Surgery). For Cohort 1 - Primary Surgery, approximately 372 subjects randomized in a 1:1 ratio (i.e., chemotherapy with oregovomab or chemotherapy with placebo). For Cohort 2 - NACT + Interval Surgery, approximately 230 subjects will be randomized in a 1:1 ratio (i.e., chemotherapy with oregovomab or chemotherapy and placebo).

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: FEMALE

Healthy Volunteers: No

Locations

Honor Health, Phoenix, Arizona, United States

The University of Arizona Cancer Center, Tucson, Arizona, United States

John Muir Health Clinical Research Center, Concord, California, United States

Kaiser Permanente Southern California, Irvine, California, United States

Moores UC San Diego Cancer Center, La Jolla, California, United States

Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States

Epic Care, Pleasant Hill, California, United States

Kaiser Permanente Riverside Medical Center, Riverside, California, United States

University of California, Davis Comprehensive Cancer Center, Sacramento, California, United States

Contra Costa Oncology, Walnut Creek, California, United States

John Muir Health Gynecologic Cancer Services, Walnut Creek, California, United States

University of Colorado Health, Aurora, Colorado, United States

University of Connecticut Health Center, Farmington, Connecticut, United States

Smilow Cancer Hospital, New Haven, Connecticut, United States

Yale University School of Medicine, New Haven, Connecticut, United States

AdventHealth Orlando, Orlando, Florida, United States

Women's Cancer Florida/Women's Cancer Associates, Saint Petersburg, Florida, United States

Lewis Cancer & Research Pavilion at St. Joseph's Candler, Savannah, Georgia, United States

The Queens Medical Center, Honolulu, Hawaii, United States

Kapiolani Medical Center for Women and Children/University of Hawaii, Honolulu, Hawaii, United States

Parkview Research Center, Fort Wayne, Indiana, United States

Women's Cancer Care/Mary Bird Perkins Cancer Center, Covington, Louisiana, United States

Tufts Medical Center, Boston, Massachusetts, United States

Lahey Hospital and Medical Center, Burlington, Massachusetts, United States

MetroWest Medical Center, Framingham, Massachusetts, United States

Lowell General Hospital, Lowell, Massachusetts, United States

Tufts Medical Center Cancer Center in Stoneham, Stoneham, Massachusetts, United States

UMass Memorial Medical Center, Worcester, Massachusetts, United States

St. Joseph Mercy Hospital, Ann Arbor, Michigan, United States

Sparrow Hospital, Lansing, Michigan, United States

Minnesota Oncology Hematology - Mercy Hospital, Coon Rapids, Minnesota, United States

Minnesota Oncology Hematology, Edina, Minnesota, United States

University of Minnesota Health - Maple Grove Clinic, Maple Grove, Minnesota, United States

Minnesota Oncology Hematology, Minneapolis, Minnesota, United States

Metro Minnesota Community Oncology Research Consortium, Saint Louis Park, Minnesota, United States

Park Nicollet Frauenshuh Cancer Center, Saint Louis Park, Minnesota, United States

Minnesota Oncology Hematology, Saint Paul, Minnesota, United States

Nebraska Methodist Hospital, Omaha, Nebraska, United States

Portsmouth Regional Hospital, Portsmouth, New Hampshire, United States

Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

The Valley Hospital (Valley Health), Paramus, New Jersey, United States

Womens Cancer Care Associates, Albany, New York, United States

Montefiore Medical Center PRIME, Bronx, New York, United States

Mount Sinai - PRIME, Lake Success, New York, United States

Mount Sinai The Blavatnik Family Chelsea Medical Center, New York, New York, United States

Icahn School of Medicine at Mount Sinai, New York, New York, United States

Stony Brook University Hospital, Stony Brook, New York, United States

Duke University, Durham, North Carolina, United States

Duke Women's Cancer Care Raleigh, Raleigh, North Carolina, United States

SCC at UH Geauga Medical Center, Chardon, Ohio, United States

University Hospitals of Cleveland, Cleveland, Ohio, United States

Cleveland Clinic Fairview Hospital, Cleveland, Ohio, United States

Cleveland Clinic, Cleveland, Ohio, United States

Ohio State University Wexner Medical Center, Columbus, Ohio, United States

Grandview Medical Center/Kettering Medical Center, Kettering, Ohio, United States

Cleveland Clinic Hillcrest Hospital, Mayfield Heights, Ohio, United States

UH Minoff Health Center - Seidman, Orange Village, Ohio, United States

SCC at St. John's Medical Center, Westlake, Ohio, United States

University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States

Oklahoma Cancer Specialist and Research Institution, LLC, Tulsa, Oklahoma, United States

Willamette Valley Cancer Institute and Research Center, Eugene, Oregon, United States

Northwest Cancer Specialists, P.C.-Portland-Rose Quarter, Portland, Oregon, United States

Magee Women's Hospital of UPMC, Pittsburgh, Pennsylvania, United States

UPMC Hillman Cancer Center at UPMC Passavant, Pittsburgh, Pennsylvania, United States

Women & Infants Hospital of Rhode Island, Providence, Rhode Island, United States

Sanford Research/USD-Sioux Falls, Sioux Falls, South Dakota, United States

Texas Oncology, P.A. - Austin, Austin, Texas, United States

Texas Oncology, P.A., Dallas, Texas, United States

Texas Oncology, P.A. - Fort Worth, Fort Worth, Texas, United States

Memorial Herman Hospital, Houston, Texas, United States

Texas Oncology San Antonio Medical Center, San Antonio, Texas, United States

University of Virginia Health Systems, Charlottesville, Virginia, United States

Virginia Cancer Specialists, Fairfax, Virginia, United States

Virginia Oncology Associates - Hampton, Norfolk, Virginia, United States

VCU Massey Cancer Center, Richmond, Virginia, United States

Carilion Clinic Gynecological Oncology, Roanoke, Virginia, United States

MultiCare Regional Cancer Center - Auburn, Auburn, Washington, United States

MultiCare Regional Cancer Center-Gig Harbor Medical Park, Gig Harbor, Washington, United States

MultiCare Institute for Research and Innovation, Puyallup, Washington, United States

MultiCare Regional Cancer Center - Tacoma, Tacoma, Washington, United States

University of Wisconsin, Madison, Wisconsin, United States

CEMAIC - Centro Medico Privado, Córdoba, Cordoba, Argentina

Clínica Universitaria Privada Reina Fabiola, Córdoba, Cordoba, Argentina

Sanatorio de la Mujer, Rosario, , Argentina

Sanatorio Parque S.A, Salta, , Argentina

CER San Juan Centro Polivalente de Asistencia e Inv. Clinica, San Juan, , Argentina

Clinicas Viedma S.A., Viedma, , Argentina

ZNA Middelheim, Antwerpen, , Belgium

Cliniques Universitaires Saint-Luc, Bruxelles, , Belgium

Clinique CHC MontLégia, Liège, , Belgium

Centro de Pesquisas Clinica Reichow, Blumenau, , Brazil

Oncosite - Centro de Pesquisa Clinica e Oncologia, Guimaraes, , Brazil

Centro Gaucho Integrado de Oncologia, Hematologia, Ensino e Pesquisa - Hospital Mae de Deus, Porto Alegre, , Brazil

Fundação Doutor Amaral Carvalho, San Paolo, , Brazil

CEPHO - Centro de Estudos e Pesquisas de Hematologia e Oncologia, Santo André, , Brazil

Clínica São Germano - Oncologia, Sao Paulo, , Brazil

Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada

City of Health Hospital at Laval (Cité de la Santé de Laval), Laval, Quebec, Canada

CHUM Centre de Recherche (affiliated with University of Montreal), Montréal, Quebec, Canada

McGill University Health Centre/Glen Site/ Royal Victoria Hospital, Montréal, Quebec, Canada

CHUS - Hôpital Fleurimont, Sherbrooke, Quebec, Canada

Centro de Investigación Clínica Bradford Hill, Santiago, , Chile

Sociedad de Investigaciones Medicas Limitada, Temuco, , Chile

Fakultni nemocnice Hradec Kralove, Hradec Kralove, , Czechia

Fakultni nemocnice Kralovske Vinohrady, Prague, , Czechia

Fakultni nemocnice Bulovka, Praha, , Czechia

Fakultni nemocnice v Motole, Praha, , Czechia

Vseobecna fakultni nemocnice v Praze, Praha, , Czechia

Del-pesti Centrumkorhaz - Orszagos Hematologiai es Infektologiai Intezet, Budapest, , Hungary

Magyar Honvedseg Egeszsegugyi Kozpont, Budapest, , Hungary

Debreceni Egyetem, Debrecen, , Hungary

Bacs-Kiskun Megyei Oktatokorhaz, Kecskemét, , Hungary

Zala Megyei Szent Rafael Korhaz, Zalaegerszeg, , Hungary

Fortis Hospital Ltd, Bangalore, , India

Fortis Hospital Ltd, Bengaluru, , India

All India Institute of Medical Services, Delhi, , India

Max Super Specialty Hospital, Mohali, , India

Sushrut Hospital, Mumbai, , India

Fortis Hospital, Noida, , India

Deenanath Mangeshkar Hospital, Pune, , India

Ruby Hall Clinic, Pune, , India

Azienda Socio Sanitaria Territoriale di Monza (Presidio San Gerardo), Monza, , Italy

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, , Italy

Università Campus Bio-Medico di Roma, Rome, , Italy

National Cancer Center, Goyang, , Korea, Republic of

Seoul National University Bundang Hospital, Seongnam, , Korea, Republic of

Asan Medical Center, Seoul, , Korea, Republic of

Korea University Guro Hospital, Seoul, , Korea, Republic of

Samsung Medical Center, Seoul, , Korea, Republic of

Seoul National University Hospital, Seoul, , Korea, Republic of

Severance Hospital, Yonsei University Health System, Seoul, , Korea, Republic of

The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, , Korea, Republic of

Severance Hospital Yonsei University Health System, Soeul, , Korea, Republic of

Clinical Medical Research S.C., Orizaba, Veracruz, Mexico

Investigacion Onco Farmaceutica S. de R.L. de C.V. (OncoTech), La Paz, , Mexico

Universidad Autonoma de Nuevo Leon, Hospital Universitario Dr. Jose Eleuterio Gonzalez, Monterrey, , Mexico

SMIQ S. de R.L. de C.V., Querétaro, , Mexico

Centro Potosino de Investigación Medica S.C., San Luis Potosi, , Mexico

Hospital Clinic de Barcelona, Barcelona, Catalonia, Spain

Hospital Universitari Vall d'Hebron, Barcelona, Catalonia, Spain

Hospital de la Santa Creu i Sant Pau, Barcelona, , Spain

ICO l'Hospitalet-Hospital Duran i Reynals, L'Hospitalet De Llobregat, , Spain

Instituto Valenciano de Oncologia IVO, Valencia, , Spain

Taipei Veterans General Hospital, Taipei county, Taipei, Taiwan

Taichung Veterans General Hospital, Taichung, , Taiwan

National Cheng Kung University Hospital, Tainan, , Taiwan

Koo Foundation Sun Yat-Sen Cancer Center, Taipei, , Taiwan

National Taiwan University Hospital, Taipei, , Taiwan

Contact Details

Name: Sunil Gupta, MD, FRCPC

Affiliation: CanariaBio Inc.

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: